JP2010526142A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526142A5
JP2010526142A5 JP2010507416A JP2010507416A JP2010526142A5 JP 2010526142 A5 JP2010526142 A5 JP 2010526142A5 JP 2010507416 A JP2010507416 A JP 2010507416A JP 2010507416 A JP2010507416 A JP 2010507416A JP 2010526142 A5 JP2010526142 A5 JP 2010526142A5
Authority
JP
Japan
Prior art keywords
methylpyrrolidine
tartrate
phenyl
optionally
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010507416A
Other languages
English (en)
Japanese (ja)
Other versions
JP5698887B2 (ja
JP2010526142A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/005702 external-priority patent/WO2008137087A1/en
Publication of JP2010526142A publication Critical patent/JP2010526142A/ja
Publication of JP2010526142A5 publication Critical patent/JP2010526142A5/ja
Application granted granted Critical
Publication of JP5698887B2 publication Critical patent/JP5698887B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010507416A 2007-05-03 2008-05-02 (r)−2−メチルピロリジンおよび(s)−2−メチルピロリジンならびにその酒石酸塩を調製するための方法 Expired - Fee Related JP5698887B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92735607P 2007-05-03 2007-05-03
US60/927,356 2007-05-03
PCT/US2008/005702 WO2008137087A1 (en) 2007-05-03 2008-05-02 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof

Publications (3)

Publication Number Publication Date
JP2010526142A JP2010526142A (ja) 2010-07-29
JP2010526142A5 true JP2010526142A5 (cg-RX-API-DMAC7.html) 2011-06-23
JP5698887B2 JP5698887B2 (ja) 2015-04-08

Family

ID=39688886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010507416A Expired - Fee Related JP5698887B2 (ja) 2007-05-03 2008-05-02 (r)−2−メチルピロリジンおよび(s)−2−メチルピロリジンならびにその酒石酸塩を調製するための方法

Country Status (14)

Country Link
EP (1) EP2152669A1 (cg-RX-API-DMAC7.html)
JP (1) JP5698887B2 (cg-RX-API-DMAC7.html)
KR (1) KR20100017565A (cg-RX-API-DMAC7.html)
CN (1) CN101679237A (cg-RX-API-DMAC7.html)
AU (1) AU2008248168B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0810330A2 (cg-RX-API-DMAC7.html)
CA (1) CA2686033A1 (cg-RX-API-DMAC7.html)
EA (1) EA019031B1 (cg-RX-API-DMAC7.html)
IL (1) IL201627A (cg-RX-API-DMAC7.html)
MX (1) MX2009011787A (cg-RX-API-DMAC7.html)
NZ (1) NZ580948A (cg-RX-API-DMAC7.html)
UA (1) UA99913C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008137087A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200907643B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008013838A2 (en) 2006-07-25 2008-01-31 Cephalon, Inc. Pyridizinone derivatives
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
MX2010008384A (es) * 2008-01-30 2010-11-30 Cephalon Inc Derivados de piridazina substituida, con actividad antagonista de h3 de histamina.
JP6849594B2 (ja) * 2014-12-23 2021-03-24 セファロン、インク. 縮合二環式2,4−ジアミノピリミジン誘導体を調整する方法
CN112638869B (zh) * 2018-09-07 2025-04-25 赛诺菲 6-(2,4-二氯苯基)-5-[4-[(3s)-1-(3-氟丙基)吡咯烷-3-基]氧基苯基]-8,9-二氢-7h-苯并[7]轮烯-2-甲酸甲酯的盐及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329974A1 (de) 1983-08-19 1985-02-28 Bayer Ag, 5090 Leverkusen Herstellung von hydrierten nitrilkautschuken
DE3433392A1 (de) 1984-09-12 1986-03-20 Bayer Ag, 5090 Leverkusen Hydrierung nitrilgruppenhaltiger ungesaettigter polymerer
FR2714849B1 (fr) 1994-01-13 1996-04-05 Inst Francais Du Petrole Procédé de préparation d'un catalyseur d'hydrogénation soluble en phase liquide organique.
DE4403479A1 (de) 1994-02-04 1995-08-10 Basf Ag Verfahren zur Herstellung von Hydroxylammoniumsalzen
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US7153889B2 (en) 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
EP1739104B1 (en) 2004-03-08 2014-07-09 Japan Science and Technology Agency Polymer-supported metal cluster compositions
US7145005B2 (en) 2004-05-12 2006-12-05 Abbott Laboratories 2-(6-{2-[(2R)-2-Methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
CA2566526C (en) 2004-06-02 2012-10-23 F. Hoffmann-La Roche Ag Naphthaline derivatives useful as histamine-3-receptor ligands
WO2006059778A1 (ja) 2004-12-01 2006-06-08 Banyu Pharmaceutical Co., Ltd. 置換ピリドン誘導体
ATE496892T1 (de) 2004-12-17 2011-02-15 Janssen Pharmaceutica Nv Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen
MX2007008843A (es) 2005-01-21 2007-08-22 Schering Corp Derivados de imidazol y bencimidazol utiles como antagonistas de histamina h3.
JP2008534542A (ja) 2005-03-31 2008-08-28 ユセベ ファルマ ソシエテ アノニム オキサゾール部分又はチアゾール部分を含む化合物、それらの製造方法及びそれらの使用
GB0514812D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
CA2627234A1 (en) 2005-10-27 2007-05-03 Ucb Pharma, S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
DK1988777T3 (da) 2006-02-09 2012-01-16 Athersys Inc Pyrazoler til behandling af fedme og andre cns-lidelser
WO2007099423A1 (en) 2006-03-02 2007-09-07 Pfizer Products Inc. 1-pyrrolidine indane derivatives as histamine-3 receptor antagonists
EP2007749A2 (en) 2006-03-13 2008-12-31 Pfizer Products Inc. Tetralines antagonists of the h-3 receptor
EP2035372A1 (en) 2006-06-29 2009-03-18 Arena Pharmaceuticals, Inc. Modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
WO2008013838A2 (en) 2006-07-25 2008-01-31 Cephalon, Inc. Pyridizinone derivatives

Similar Documents

Publication Publication Date Title
JP7413363B2 (ja) メチル6-(2,4-ジクロロフェニル)-5-[4-[(3s)-1-(3-フルオロプロピル)ピロリジン-3-イル]オキシフェニル]-8,9-ジヒドロ-7h-ベンゾ[7]アヌレン-2-カルボキシレートの調製方法
JP2786480B2 (ja) 1―インドリルアルキル―4―(置換ピリジニル)ピペラジン
JP3085708B2 (ja) ピペラジン誘導体
KR20200131241A (ko) 2종의 4-{[(2s)-2-{4-[5-클로로-2-(1h-1,2,3-트리아졸-1-일)페닐]-5-메톡시-2-옥소피리딘-1(2h)-일}부타노일]아미노}-2-플루오로벤즈아미드 유도체의 제조 방법
TW201215601A (en) Method for producing 1-triazole-2-butanol derivative
CN101993405B (zh) 吲哚啉衍生物、及其制备方法和用途
JP2005511712A (ja) 4,5−ジヒドロ−ピラゾロ[3,4−c]ピリド−2−オンの合成
JP2011042671A (ja) ピリジルテトラヒドロピリジン類及びピリジルピペリジン類とそれらの製造方法
HUT65837A (en) Process for producing phenoxy- and phenoxyalkyl-piperidines and pharmaceutical preparations containing them
RU2480461C2 (ru) Способ получения иматиниба и его промежуточных соединений
JPH10503501A (ja) 抗喘息、抗アレルギー、抗炎症及び免疫修飾作用を有するインドール、インダゾール、ピリドピロール及びピリドピラゾール誘導体
JP2010526142A5 (cg-RX-API-DMAC7.html)
JP3269574B2 (ja) メタノアントラセン化合物、これを含有する神経精神障害を治療するための調剤学的組成物、およびこの化合物を製造するための方法および中間体
US20110021779A1 (en) Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
ES2561834T3 (es) Naftiridonas y quinolonas 7-amino alquilidenil-heterocíclicas
JP5698887B2 (ja) (r)−2−メチルピロリジンおよび(s)−2−メチルピロリジンならびにその酒石酸塩を調製するための方法
JP2002535365A (ja) 抗うつ性複素環化合物
ZA200308634B (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders.
KR20150046456A (ko) 신규한 항진균성 옥소다이하이드로피리딘카보하이드라자이드 유도체
JP7252978B2 (ja) 2-(1-(tert-ブトキシカルボニル)ピペリジン-4-イル)安息香酸を調製するためのプロセス
SU680648A3 (ru) Способ получени производных пиперидина или их кислотноаддитивных солей
JPH01125366A (ja) α−(アルキルフェニル)−4−(ヒドロキシジフェニルメチル)−1−ピペリジンブタノールの製造方法
SU587861A3 (ru) Способ получени производных -диоксан-5-метиламина
JP2840855B2 (ja) ジヒドロピリジン誘導体の製造方法
WO2006118257A1 (ja) インダゾール-3-イルメチルホスホニウム塩の製造法